Doer Biologics
Chemicals & Related Products · United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.doerbio.comRevenue
$11.1 MillionIndustry
About Doer Biologics
Doer Biologics Org Chart
Is Doer Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Doer Biologics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Doer Biologics has recently received funding, and reach out quickly before it becomes old news!
Check out if Doer Biologics is spiking on competitors!
Earning: See what the market has to say on Doer Biologics recently announced quarterly report
Click to see if Doer Biologics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Doer Biologics
Doer Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Doer Biologics has new funding data
Recommended Actions
Find VP level buyers at Doer Biologics
Find 2 more new buyers
Compare Similar Companies to Doer Biologics
Compare insights from companies similar to Doer Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Doer Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Doer Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Doer Biologics.
Doer Biologics Tech Stack
A closer look at the technologies used by Doer Biologics
Top Chemicals & Related Products Companies
Frequently Asked Questions Regarding Doer Biologics
浙江道尔生物科技有限公司, established in April 2014, is a high-tech enterprise specializing in the development of innovative biopharmaceuticals under the East China Pharmaceutical Group. The company focuses on advanced technology platforms such as xLONGylation, MultipleBody, and AccuBody for precision cancer treatment. Their intended clients include healthcare... Read More